What Comes After the FDA’s Drug Monopoly?

Private certification, insurer evaluation and peer-reviewed research step up.

Stereotaxis receives FDA clearance for robotic surgical device

Stereotaxis Inc. (NYSE: STXS), St. Louis-based developer of robotic technologies to treat arrhythmias and perform ...